Login / Signup

Druggable differences: Targeting mechanistic differences between trans-translation and translation for selective antibiotic action.

Pooja SrinivasKenneth C KeilerChristine M Dunham
Published in: BioEssays : news and reviews in molecular, cellular and developmental biology (2022)
Bacteria use trans-translation to rescue stalled ribosomes and target incomplete proteins for proteolysis. Despite similarities between tRNAs and transfer-messenger RNA (tmRNA), the key molecule for trans-translation, new structural and biochemical data show important differences between translation and trans-translation at most steps of the pathways. tmRNA and its binding partner, SmpB, bind in the A site of the ribosome but do not trigger the same movements of nucleotides in the rRNA that are required for codon recognition by tRNA. tmRNA-SmpB moves from the A site to the P site of the ribosome without subunit rotation to generate hybrid states, and moves from the P site to a site outside the ribosome instead of to the E site. During catalysis, transpeptidation to tmRNA appears to require the ribosomal protein bL27, which is dispensable for translation, suggesting that this protein may be conserved in bacteria due to trans-translation. These differences provide insights into the fundamental nature of trans-translation, and provide targets for new antibiotics that may have decrease cross-reactivity with eukaryotic ribosomes.
Keyphrases
  • machine learning
  • binding protein
  • electronic health record
  • drug delivery
  • artificial intelligence
  • deep learning
  • cancer therapy
  • dna binding
  • antiretroviral therapy